New Opioid Guidelines

02/01/23 • 32 min

Special guest Laila Khalid, MD, MPH from the Albert Einstein College of Medicine Montefiore Medical Center joins us to talk about new guidelines to reinforce safe opioid use.

Listen in as they discuss what’s changed with the updated CDC opioid guidelines...and what to expect in your practice.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health

None of the speakers have anything to disclose.
Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.
Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].

Special guest Laila Khalid, MD, MPH from the Albert Einstein College of Medicine Montefiore Medical Center joins us to talk about new guidelines to reinforce safe opioid use.

Listen in as they discuss what’s changed with the updated CDC opioid guidelines...and what to expect in your practice.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health

Send us a text

Previous Episode

Triptans in Patients with Cardiovascular Risks

Headache medicine specialist Rebecca C. Burch, MD, joins us to talk about triptan use in patients with cardiovascular risk factors.
Listen in as they clear up confusion about which patients should avoid triptans due to cardiovascular concerns.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University
Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit

Send us a text

Next Episode

First-Line Meds for Type 2 Diabetes

Special guest Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University joins us to talk about medications for type 2 diabetes.

Listen in as they debate whether metformin should still be first-line for all patients with type 2 diabetes...and discuss the role of GLP-1 agonists and SGLT2 inhibitors in these patients.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit

Send us a text